Crazy Flux
  • Business
  • World
  • Stocks
  • Investing
  • Business
  • World
  • Stocks
  • Investing

Crazy Flux

Investing

Trump Tariffs to Raise US Medical Device Costs, Hospitals Hold Off on Stockpiling

by admin July 11, 2025
July 11, 2025
Trump Tariffs to Raise US Medical Device Costs, Hospitals Hold Off on Stockpiling

President Donald Trump’s new round of tariffs —this time targeting copper— has intensified concerns about rising costs across key sectors, including healthcare.

But despite significant price pressures on steel, aluminum, and now copper, all vital to medical device production, there is no indication that US hospitals are stockpiling equipment ahead of expected price hikes, according to recent findings from GlobalData.

Announced earlier this week, Trump’s 50 percent tariff on copper imports matches the doubled rates already in effect for steel and aluminum.

The White House has defended these actions, imposed under Section 232 of the Trade Expansion Act of 1962, as necessary to protect US national security and revive domestic manufacturing.

But with tariffs applied indiscriminately across all import sources —excluding only the United Kingdom on certain metals—concerns are mounting over the downstream impact, especially on industries reliant on foreign raw materials.

“Although these tariffs are likely to impact distribution and increase consumer costs, some facilities may not have the financial resources to buy devices in advance,” said Amy Paterson, a medical analyst at GlobalData.

“While some markets have seen an increase in spending, it does not appear that healthcare facilities have been stocking up on medical devices in preparation for potential price increases or supply chain disruptions.”

Steel and aluminum are critical materials in the production of surgical tools, implants, diagnostic machines, and hospital infrastructure. Copper, now under the same elevated tariff level, is widely used in imaging equipment, monitors, and wiring for medical devices. All told, the latest tariff decisions mean higher input costs across a range of essential equipment.

GlobalData’s US Healthcare Facility Invoicing Database, which tracks procurement activity across 56 medical device categories, shows no significant increase in healthcare spending between January and May 2025.

Even as May and June data continue to roll in, early signs suggest healthcare purchasing behavior remains steady, not preemptive.

This spending inertia comes despite broader signals that cost pressures on US healthcare providers may worsen. Unlike certain exemptions applied to pharmaceuticals or food products, the latest tariffs make no carveouts for medical equipment or life-saving devices.

This means that hospitals, who are already facing tight budgets and post-pandemic financial strain, may have to absorb higher equipment costs or pass them on to patients.

Taken together, the policy shifts and trade actions illustrate a broader Trump administration approach centered on cutting international dependencies, regardless of sector.

In metals, the administration argues, cheap imports from China and elsewhere have flooded global markets, putting US producers out of business and threatening industrial self-sufficiency.

The move to double tariffs on steel and aluminum reflects that ambition. Copper, added to the list this week, signals a continued hardline stance that could affect everything from defense manufacturing to consumer electronics.

The US imports more than half its aluminum and about one-third of its copper, much of it from countries like Canada and Chile.

By raising costs on these materials, the administration hopes to encourage domestic mining and refining. However, in the short term, US industries are bearing the brunt.

Securities Disclosure: I, Giann Liguid, hold no direct investment interest in any company mentioned in this article.

This post appeared first on investingnews.com

previous post
OpenAI to release web browser in challenge to Google Chrome
next post
Ekin Ober on Why AI Could Be Mining’s Most Valuable Tool Yet

Related Posts

JZR Gold: Near-term Cash Flow with Significant Upside...

October 16, 2025

Mawson Finland Announces Upsize of Brokered Private Placement

February 15, 2025

Independent Survey Confirms Public Support for Falco Horne...

March 19, 2025

AF2 Capital Corp. Enters into Letter of Intent...

October 17, 2025

Freegold Ventures Limited – Results of the Annual...

June 28, 2025

NevGold Releases Some of the Highest Grade Oxide...

June 26, 2025

Finlay Minerals Announces Closing of Non-Brokered Private Placement...

June 10, 2025

Rule, Kiyosaki, Spina and Clark Share Mining Stock...

February 4, 2025

Tech 5: Softbank to Invest US$2 Billion in...

August 24, 2025

Newmont to Exit Toronto Stock Exchange as Cost...

September 12, 2025

    Join our mailing list to get access to special deals, promotions, and insider information. Your exclusive benefits await! Enjoy personalized recommendations, first dibs on sales, and members-only content that makes you feel like a true VIP. Sign up now and start saving!


    By opting in you agree to receive emails from us and our affiliates. Your information is secure and your privacy is protected.

    Recent

    • The Real Drivers of This Market: AI, Semis & Robotics

      October 23, 2025
    • S&P 500 Breaking Out Again: What This Means for Your Portfolio

      October 23, 2025
    • Collie land acquisition & approvals move ahead

      October 23, 2025
    • High stakes and blue sky as Augustus lines up for PNG golden prize

      October 23, 2025
    • Apollo Silver Closes Initial $25 Million Tranche of Private Placement Offering

      October 23, 2025
    • Chevron Extends Partnership with REM in Major Contract Award

      October 23, 2025
    • About us
    • Contacts
    • Privacy Policy
    • Terms and Conditions
    • Email Whitelisting

    Disclaimer: crazyflux.com, its managers, its employees, and assigns (collectively “The Company”) do not make any guarantee or warranty about what is advertised above. Information provided by this website is for research purposes only and should not be considered as personalized financial advice. The Company is not affiliated with, nor does it receive compensation from, any specific security. The Company is not registered or licensed by any governing body in any jurisdiction to give investing advice or provide investment recommendation. Any investments recommended here should be taken into consideration only after consulting with your investment advisor and after reviewing the prospectus or financial statements of the company.


    Copyright © 2025 crazyflux.com | All Rights Reserved